US-listed product tanker owners were taking on more losses in early trading Friday after a bloody Thursday that saw two top ...

For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...

Presentation Operator Thank you for standing-by. My name is Jeanine and I will be your conference operator for today. At this ...

Piper Sandler 36th Annual Healthcare Conference: Presentation Tuesday, December 3, 2024 at 8:00 am ET7th Annual Evercore HealthCONx Conference: Presentation Thursday, December 5, 2024 at 12:30 pm ...

The presentation is scheduled to take place on ... will participate in the 7th Annual Evercore HealthCONx Conference, being held at the Loews Coral Gables Hotel, in Florida on December 3-5 ...

NEW YORK--(BUSINESS WIRE)--Evercore (NYSE: EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business ...

Evercore (NYSE: EVR) announced today that David Kamo has joined the firm as a senior managing director to support its growing financial sponsor M&A advisory business,based in New York. “We are ...

However, citing its channel checks with senior AI engineers at major hyperscalers, Evercore notes that while DeepSeek offers cost improvements, these are seen as “evolutionary rather than ...

In a report released on February 7, Michael Binetti from Evercore ISI maintained a Buy rating on Tapestry (TPR – Research Report), with a price target of $97.00. The company’s shares closed ...

In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $515.00. The company’s shares ...

However, citing its channel checks with senior AI engineers at major hyperscalers, Evercore notes that while DeepSeek offers cost improvements, these are seen as “evolutionary rather than ...